Open AccessBASILIXIMAB (SIMULECT®) IS SAFE AND WELL TOLERATED IN ADULT LIVER TRANSPLANTATION AND PROVIDES A LOW RATE OF ACUTE REJECTION.
Author(s) -
Yvon Calmus,
J. Scheele,
I. GonzalezPinto Arillaga,
Emmanuel Mas,
E. Klar,
G.P. Pageaux,
Charles H. Scudamore,
Valentín Cuervas-Mons,
H.J. Metselaar,
Danièle Girault
Publication year - 2000
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200004271-00195
Subject(s) - basiliximab , medicine , transplantation , liver transplantation , urology , gastroenterology , kidney transplantation